Author

Kirstin Mösbauer

Berlin Institute of Health at Charité - Universitätsmedizin Berlin

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioinformatics· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:protein structure prediction· 1 Assay:proteomics· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

Christian DrosteniD· 2 shared Emanuel WyleriD· 2 shared Markus LandthaleriD· 2 shared Matthias SelbachiD· 2 shared Tommaso MariiD· 2 shared Altuna AkaliniD· 1 shared Andranik IvanoviD· 1 shared Andreas Christian HockeiD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Christian DrostenORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsJournal of Proteome ResearchPeer-reviewedMay 24, 2022

In vitro Kinase-to-Phosphosite database (iKiP-DB) predicts kinase activity in phosphoproteomic datasets

Tommaso Mari, Kirstin Mösbauer, Emanuel Wyler…·Matthias Selbach

The paper introduces iKiP-DB, a database that predicts kinase activity from phosphoproteomic data, showing its effectiveness in analyzing both well-known and understudied kinases.

70 citations

humanproteomics

𝕏 PostBluesky

Systems BiologyiSciencePeer-reviewedFeb 7, 2021

Bulk and single-cell gene expression profiling of SARS-CoV-2 infected human cell lines identifies molecular targets for therapeutic intervention

Emanuel Wyler, Kirstin Mösbauer, Vedran Franke…·Markus Landthaler

The paper uses bulk and single-cell transcriptomics to analyze SARS-CoV-2 infection in human cell lines, identifying HSP90 as a potential therapeutic target.

317 citationstop 1%

humanbulk RNA-seq

𝕏 PostBluesky